| Title: |
Exploring Corporate Capital Structure and Overleveraging in the Pharmaceutical Industry. |
| Authors: |
Issa, Samar1 (AUTHOR) sissa@saintpeters.edu; Issa, Hussein2 (AUTHOR) hussein.issa@rutgers.edu |
| Source: |
Risks. Feb2025, Vol. 13 Issue 2, p26. 33p. |
| Subject Terms: |
*FINANCIAL crises; *CORPORATE debt; *DEBT management; *PHARMACEUTICAL industry; *FINANCIAL risk; FLOW instability; COUNTERPARTY risk |
| Abstract: |
This paper applies an empirical model of corporate capital structure, optimal debt, and overleveraging to estimate overleveraging measured as the difference between actual and optimal debt. Estimated using a sample of the twenty largest pharmaceutical firms, covering the time span from 2000 to 2018, the model sheds light on an industry-specific default risk. The analysis presented in this paper reveals a concerning trend in the pharmaceutical industry, with corporate excess debt steadily increasing over the past two decades, particularly peaking during the 2008 crisis and after 2013. These findings underscore the critical role of excess debt in exacerbating financial instability and highlight the pharmaceutical sector's unique challenges, including high R&D intensity and regulatory pressures. By quantifying overleveraging and linking it to financial risk, the paper offers valuable policy implications, emphasizing the need for proactive management of optimal debt levels to mitigate default risks and enhance macroeconomic resilience. [ABSTRACT FROM AUTHOR] |
| : |
Copyright of Risks is the property of MDPI and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Business Source Premier |